Bio:Dr. Tarcic joined NovellusDx in July 2012, bringing with him more than a decade of experience in cancer cell biology and signal transduction. Starting as a project manager he is now leading the R&D and clinical activities in NovellusDx including R&D design, IP production, strategic planning, multidisciplinary team management and business development.

Gabi holds a Ph.D. from the Weizmann Institute of Science, where he trained in the lab of Prof. Yosef Yarden. During this time, Dr. Tarcic published his research widely in leading peer- reviewed scientific journals. He also co-edited a book entitled Vesicle Trafficking in Cancer, which was published by Springer Press, the leading publisher of medical and scientific literature. Dr. Tarcic received his B.Sc. with honors from the Hebrew University in Jerusalem and a Ph.D. from the Weizmann Institute of Science.